Dr. Michele Russo got his MSc in 2015 at the University of Naples “Federico II”, Naples, Italy, where he got a strong background in Molecular Immuno-Oncology. Since 2016 he is PhD student in the Department of Translational Medical Sciences, University of Naples “Federico II”, on cardiovascular diseases and heart failure. His ongoing studies in the emerging field of Cardio-Oncology at Molecular Biotechnology Center of University of Torino under the supervision of Prof. Alessandra Ghigo, brought him to investigate the effect of chemotherapy regimens on both cancer progression and heart function. The main goal of his current research is to understand the events, promoted by chemotherapy and leading to cardiac dysfunction, with the aim of developing new therapeutic strategies to prevent antineoplastic-induced cardiotoxicity.